在心力衰竭 (iNIX-HF) 第二阶段临床试验中无机NItrate和eXercise的性能:理由和研究设计
Andrew R Coggan1, Lauren K Park2, Susan B Racette3
1Department of Kinesiology, School of Health & Human Sciences, And Indiana Center for Musculoskeletal Health, School of Medicine, Indiana University Purdue University Indianapolis, Indianapolis, IN, USA.
Contemporary clinical trials communications
|October 16, 2023
概括
无机酸盐补充剂可能会改善心力衰竭患者的运动能力,减少喷射率 (HFrEF). 这项研究研究了它的有效性,为HFrEF患者提供了一个新的,可访问的治疗选择.
科学领域:
- 心血管医学 心血管医学
- 运动生理学 运动生理学
- 营养科学 营养科学
背景情况:
- 减少喷射分数 (HFrEF) 的心力衰竭显著降低了运动能力.
- 减少氧化 (NO) 的生物可用性是与HFrEF相关的骨肌肉功能障碍的一个关键因素.
- 无机酸盐补充剂是一种增强NO生产的潜在策略.
研究的目的:
- 评估无机酸盐 (酸,KNO3) 对HFrEF患者运动表现的急性和长期疗效.
- 评估KNO3作为一种用于提高HFrEF运动能力的新型治疗干预措施.
- 为更大规模的III期临床试验收集初步数据.
主要方法:
- 这是一项双盲,安慰剂控制,随机化试验,涉及75名HFrEF患者.
- 参与者每天接受10毫摩尔KNO3或安慰剂,持续6周.
- 主要结局包括肌肉功率 (同位素动力学) 和峰值有氧能力 (VO2峰值).
主要成果:
- 该研究旨在检测KNO3补充剂 (P <0.05) 显著改善肌肉力量和VO2峰值.
- 分析将比较一次剂量的急性影响与6周后的长期影响.
- 初步发现将指导未来的大规模试验.
结论:
- 在HFrEF中,无机酸盐补充剂显示出作为一种安全有效的治疗方法来提高运动表现的承诺.
- 这种方法可以通过改善HFrEF的数百万人的生活质量来提供显著的公共卫生效益.
- 需要在III期试验中进行进一步的研究,以证实这些益处,并探索更广泛的心血管终点.
更多相关视频
04:20Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
Published on: October 1, 2019
5.8K
07:40Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training
Published on: October 10, 2019
7.3K
相关概念视频
01:16Antianginal Drugs: Nitrates and β-Blockers
609
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
609
01:30Heart Failure V: Medical Management
10
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
10
01:26Heart Failure Drugs: Inotropic Agents
598
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
598
01:22Heart Failure Drugs: β-Blockers
346
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
346
01:29Heart Failure II: Pathophysiology
14
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
14
01:30Heart Failure VII: Nursing Interventions
85
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
85